Delivery Order SPE2DB24D8001-SPE2DB24FKYYA
Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBPZE, was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $16,771.40 Firm Fixed Price Delivery Order contract is for the provision of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a performance period through November 7, 2023. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $9,456.99 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with an ultimate completion date of October 18, 2024. This award is part of Dakota Drug, Inc.'s Indefinite Delivery Contract (IDC) SPE2DB24D8001 valued at $999,999,999.00, which allows the company to provide a comprehensive range of...
- This federal contract award, with ID SPE2DX15D8001|SPE2DX24FBQKX, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $11,091.23 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML pharmaceutical products. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, as part of the DLA Troop Support Medical's...
- This federal contract award, with ID SPE2DB24D8001|SPE2DB25FKZKH, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $9,440.85, is a delivery order for the pharmaceutical product STELARA 90 MG/ML SYRINGE. It is a firm fixed-price contract with a period of performance extending through March 20, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at...
- This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKZBM, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $11,352.56 firm fixed-price delivery order is for the provision of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA...
- This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKZDM, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $9,583.28. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Dakota Drug, Inc. holds with the DLA, valued at $999,999,999.00. The IDC is part of the DLA...
- This federal contract award, identified as SPE2DX15D8002|SPE2DX24F2UV0, was made by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $12,512.79 firm fixed-price delivery order is for the provision of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a performance period extending to February 7, 2024. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $20,476.24 firm fixed-price delivery order is for the pharmaceutical product STELARA 90 MG/ML SYRINGEML, with a period of performance through February 27, 2024. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's...
- This federal contract award, SPE2DB24D8002|SPE2DB25FJNGC, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $12,239.65 firm fixed-price delivery order is for STELARA 90 MG/ML SYRINGEML, a pharmaceutical product. This award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) SPE2DB24D8001 with the DLA Troop Support Medical division, valued at $999,999,999.00, which allows the company to provide a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $8,445.88, is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a performance period ending on March 18, 2025. The contract is a delivery order issued under Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, which has a total potential value of...